Abstract
The obesity hypoventilation syndrome (OHS) characterized by persistent hypercapnia with obesity has many causes. Probably the most common cause is the obstructive sleep apnea syndrome and related conditions, but some cases may occur along with depressed chemosensitivity and few apneas during sleep. The mechanisms that produce waking hypercapnia are still uncertain. Treatment of OHS consists of weight management and sometimes requires treatment with continuous applied pressure or non invasive positive pressure ventilation.
Current Respiratory Medicine Reviews
Title: The Obesity Hypoventilation Syndrome
Volume: 4 Issue: 2
Author(s): Neil S. Cherniack
Affiliation:
Abstract: The obesity hypoventilation syndrome (OHS) characterized by persistent hypercapnia with obesity has many causes. Probably the most common cause is the obstructive sleep apnea syndrome and related conditions, but some cases may occur along with depressed chemosensitivity and few apneas during sleep. The mechanisms that produce waking hypercapnia are still uncertain. Treatment of OHS consists of weight management and sometimes requires treatment with continuous applied pressure or non invasive positive pressure ventilation.
Export Options
About this article
Cite this article as:
Cherniack S. Neil, The Obesity Hypoventilation Syndrome, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222740
DOI https://dx.doi.org/10.2174/157339808784222740 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cutaneomeningospinal Angiomatosis (Cobb Syndrome) in a Young Patient
CNS & Neurological Disorders - Drug Targets Use of Antiplatelet Drugs in the Treatment of Acute Coronary Syndromes
Cardiovascular & Hematological Disorders-Drug Targets Host-Cell Survival and Death During Chlamydia Infection
Current Immunology Reviews (Discontinued) Atrial Fibrillation Following Cardiac Surgery: Established and Emerging Strategies of Prevention
Recent Patents on Cardiovascular Drug Discovery Caffeic Acid, A Versatile Pharmacophore: An Overview
Mini-Reviews in Medicinal Chemistry VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Evolving Concepts Concerning Cardiac β-Adrenoceptor Function in Heart Failure
Current Pharmaceutical Design Prevention of Intracerebral Haemorrhage
Current Drug Targets NADPH and Iron May Have an Important Role in Attenuated Mucosal Defense in Helicobacter pylori Infection?
Mini-Reviews in Medicinal Chemistry Mitochondria: the Headquarters in Ischemia-Induced Neuronal Death
Central Nervous System Agents in Medicinal Chemistry Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Current Neuropharmacology Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?
Current Pharmaceutical Design The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke
Current Pharmaceutical Design Hypoxia Inducible Factor-1 as a Therapeutic Target in Cerebral Ischemia
Current Signal Transduction Therapy Tissue Engineering a Small Diameter Vessel Substitute: Engineering Constructs with Select Biomaterials and Cells
Current Vascular Pharmacology Vasopressin in Liver Disease – Should We Turn On or Off?
Current Clinical Pharmacology Targeting Platelet G-Protein Coupled Receptors (GPCRs): Looking Beyond Conventional GPCR Antagonism
Current Vascular Pharmacology Angiotensin II-Vasopressin Interactions in The Regulation of Cardiovascular Functions. Evidence for an Impaired Hormonal Sympathetic Reflex in Hypertension and Congestive Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Herb-Drug Interactions in Neurological Disorders: A Critical Appraisal
Current Drug Metabolism